Previous Article | Next Article ![]()
Infection and Immunity, September 1999, p. 4912-4916, Vol. 67, No. 9
Kuzell Institute for Arthritis and Infectious
Diseases, California Pacific Medical Center Research Institute, San
Francisco, California 94115,1 and
Laboratory of Electron Microscopy, Department of
Pediatrics, University of California, San Francisco, San Francisco,
California 941432
Received 22 March 1999/Returned for modification 10 May
1999/Accepted 2 June 1999
Mycobacterium avium is an intracellular pathogen that
has been shown to invade macrophages by using complement receptors in vitro, but mycobacteria released from one cell can enter a second macrophage by using receptors different from complement receptors. Infection of CD18 (
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Role of Complement Receptors in Uptake of
Mycobacterium avium by Macrophages In Vivo: Evidence from
Studies Using CD18-Deficient Mice
2 integrin) knockout mice and the C57
BL/6 control mice led to comparable levels of tissue infection at 1 day, 2 days, 1 week, and 3 weeks following administration of bacteria. A histopathological study revealed similar granulomatous lesions in the
two mouse strains, with comparable numbers of organisms. In addition,
transmission electron microscopy of spleen tissues from both strains of
mice showed bacteria inside macrophages. Our in vivo findings support
the hypothesis that M. avium in the host is likely to use
receptors other than CR3 and CR4 receptors to enter macrophages with
increased efficiency.
*
Corresponding author. Mailing address: Kuzell
Institute, 2200 Webster St., Suite 305, San Francisco, CA 94115. Phone:
(415) 561-1734. Fax: (415) 441-8548. E-mail:
luizb{at}cooper.cpmc.org.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|